Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Healthtrust
Dow
Fish and Richardson
Cantor Fitzgerald
Julphar
Express Scripts
UBS
Cipla
Johnson and Johnson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,088,934

« Back to Dashboard

Summary for Patent: 8,088,934
Title:Composition and method for stabilizing the same
Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.
Inventor(s): Ueno; Ryuji (Montgomery, MD), Habe; Tsuyoshi (Sasayama, JP)
Assignee: SUCAMPO AG (Zurich, CH)
Application Number:12/144,000
Patent Claims: 1. A bi-cyclic compound represented by the formula: ##STR00021## 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo[4.3.0]nona- ne-8-one-7-yl]heptanoic acid, or a salt, ether, ester or amide thereof, in which the bi-cyclic compound is present in a ratio of substantially 100:0 with respect to its tautomeric monocyclic compound.

2. A bi-cyclic compound represented by the formula: ##STR00022## 7-[(1R,6R,7R)-3-[(3S)-1,1-difluoro-3-methylpentyl]-3-hydroxy-2-oxabicyclo- [4.3.0]nonane-8-one-7-yl]heptanoic acid or a salt, ether, ester or amide thereof, in which the bi-cyclic compound is present in a ratio of substantially 100:0 with respect to its tautomeric monocyclic compound.

3. The compound of claim 1, in which the bi-cyclic compound is: ##STR00023## 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo [4.3.0]nonane-8-one-7-yl]heptanoic acid.

4. The compound of claim 2, in which the bi-cyclic compound is: ##STR00024## 7-[(1R,6R,7R)-3-[(3S)-1,1-difluoro-3-methylpentyl]-3-hydroxy-2-oxabicyclo- [4.3.0]nonane-8-one-7-yl]heptanoic acid.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Queensland Health
AstraZeneca
Mallinckrodt
US Army
Express Scripts
Covington
Fuji
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot